Nestle has divested its peanut allergy treatment business, Palforzia, to biopharmaceutical company Stallergenes Greer. Nestle will receive milestone payments and ongoing royalties from the transaction.
An experimental skin patch called Viaskin might help young children who have strong reactions to peanuts. The patch is designed to train the body to deal with the food allergy. The patch is covered with a small amount of peanut protein that the skin takes in. A daily patch is worn in the upper-middle part of the back, where young children cannot pull it off. After 12 months, researchers said the children who took the skin-based treatment showed more tolerance or less severe reactions than those who had taken no effective treatment, or a placebo.